Luoyang Pu-Like Bio-Engineering Company Limited is a high-tech private joint stock enterprise with domestic-abroad cooperation, which was dynamically authenticated by the China Ministry of Agriculture in terms of GMP Qualification. The company is affiliated with Luoyang Huizhong strategic alliance enterprise group, and it located in Luoyang High-tech Development Zone, with 491 employees, among whom 87.5% in undergraduate degree, 3 in Ph. D and 35 in master.
There are 96,000 square meters in acreage in manufacture workshops, however, the floorage occupies 33,500 square meters. The total investment in the fixed assets is 168 million RMB. The manufacturing lines involved in such as cell culture for live vaccine, allantoic fluid live vaccine, live bacterial vaccine, two cell cultures for inactivated vaccine, two allantoic fluid inactivated vaccine, bacterial inactivated vaccine and yolk immune antibody. There are three workshops and six manufacturing lines in medical drug factory. The products involved in such as freeze-dry powder injection, water solution injection and/or oral liquid, granule, and powder injection.
   Henan Provincial Veterinary Medicine Engineering Center of Technique and Research has been built and operated, which supported by Pu-like company. The total investment is 60 million RMB. There are 6,600 square meters and the laboratory animal building is 3,000 square meters. There are 97 employees in the center, among whom 50% in master degree. The center have been developed 5 national new veterinary vaccines such as the Newcastle Disease, Infectious Bronchitis, Egg Drop Symptom and Avian Influenza (H9 subtype) United Inactivated Vaccine, the Newcastle Disease, Infectious Bronchitis and Avian Influenza (H9 subtype) United Inactivated Vaccine and some national new veterinary medicines such as Ceftiofur freeze-dry powder for injection. The ability of research and new products development will be the leader position in veterinary medicine industry.